The flagship event of the Microbiome Movement, designed for industry leaders to help accelerate the precise translation of microbiome R&D from disease causation into safe, effective and commercially scalable therapeutics..
Situated at the heart of therapeutic R&D,this meeting is focused on helping large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
The only end-to-end meeting exclusively designed for industry and researchers to help discover, deliver and commercialize microbial research into products that increase yield, enhance productivity and maximize return.
The only dedicated conference to help prebiotic, probiotic, food and pharmaceutical manufacturers commercialize the microbiome into next-generation food and nutrition products that are proven to improve human health.
A dedicated meeting to help large pharma, biotech, and academic researchers unlock the potential of the gut-brain axis in demonstrating disease causation and translating these findings into safe and effective therapeutic candidates.
Novotel Paris Est
1 Avenue de la République,
Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.